Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
195.57
+10.21 (5.51%)
Feb 6, 2026, 1:04 PM EST - Market open
Biogen Stock Forecast
Stock Price Forecast
The 22 analysts that cover Biogen stock have a consensus rating of "Buy" and an average price target of $181.77, which forecasts a -7.06% decrease in the stock price over the next year. The lowest target is $115 and the highest is $255.
Price Target: $181.77 (-7.06%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 5 | 5 | 4 | 4 | 5 | 5 |
| Hold | 16 | 14 | 13 | 11 | 13 | 13 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 25 | 23 | 22 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $205 → $225 | Buy | Maintains | $205 → $225 | +15.05% | Jan 30, 2026 |
| Citigroup | Citigroup | Hold Maintains $180 → $185 | Hold | Maintains | $180 → $185 | -5.40% | Jan 27, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $142 → $190 | Hold | Maintains | $142 → $190 | -2.85% | Jan 8, 2026 |
| Citigroup | Citigroup | Hold Maintains $153 → $180 | Hold | Maintains | $153 → $180 | -7.96% | Jan 7, 2026 |
| UBS | UBS | Hold Initiates $130 → $185 | Hold | Initiates | $130 → $185 | -5.40% | Jan 7, 2026 |
Financial Forecast
Revenue This Year
10.02B
from 9.68B
Increased by 3.60%
Revenue Next Year
9.51B
from 10.02B
Decreased by -5.09%
EPS This Year
15.27
from 11.18
Increased by 36.55%
EPS Next Year
15.21
from 15.27
Decreased by -0.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.6B | 10.3B | ||||
| Avg | 10.0B | 9.5B | ||||
| Low | 9.5B | 8.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.9% | 2.9% | ||||
| Avg | 3.6% | -5.1% | ||||
| Low | -1.7% | -16.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 17.01 | 17.98 | ||||
| Avg | 15.27 | 15.21 | ||||
| Low | 14.32 | 10.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 52.2% | 17.8% | ||||
| Avg | 36.5% | -0.3% | ||||
| Low | 28.1% | -29.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.